Literature DB >> 27041413

Self-Assembled Thermoresponsive Nanogels Prepared by Reverse Micelle → Positive Micelle Method for Ophthalmic Delivery of Muscone, a Poorly Water-Soluble Drug.

Guohua Wang1, Qixia Nie1, Chen Zang1, Baoxian Zhang2, Qiong Zhu1, Gan Luo1, Shuang Wang1.   

Abstract

This study aimed to design a nanocarrier ophthalmic delivery system of muscone, a poorly water-soluble drug. The muscone thermoresponsive nanogels were self-assembled by reverse micelle → positive micelle method. Muscone was demonstrated to have uniform narrow particle size distribution in nanogel by the dynamic light scattering test. The developed nanocomposite hydrogel had a high muscone loading, and the rheology results showed that the phase transition temperature was 34.05°C. Thixotropy test indicated that the nanogel was able to resist the blinking of eyes because of the thixotropy recovery time, which is <5 s. Compared with muscone eye drops, muscone nanogels showed longer retention time on the corneal surface using fluorescent labeling technology and produced a 3.4-fold increase in apparent permeability coefficients (Papp). Draize testing showed that the developed nanogel caused no eye irritation. In vivo pharmacokinetic study indicated that the nanogel could significantly increase the bioavailability of muscone after administration compared with eye drops. These results indicate that self-assembled thermoresponsive nanogel prepared by reverse micelle → positive micelle method has potential for the ophthalmic delivery of poorly water-soluble drugs.
Copyright © 2016 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  gels; nanotechnology; ophthalmic drug delivery; poorly water-soluble drugs; rheology; self-assembly

Mesh:

Substances:

Year:  2016        PMID: 27041413     DOI: 10.1016/j.xphs.2016.02.014

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  8 in total

Review 1.  Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studies.

Authors:  Abhirup Mandal; Rohit Bisht; Ilva D Rupenthal; Ashim K Mitra
Journal:  J Control Release       Date:  2017-01-11       Impact factor: 9.776

Review 2.  Design strategies for physical-stimuli-responsive programmable nanotherapeutics.

Authors:  Fitsum Feleke Sahle; Muhammad Gulfam; Tao L Lowe
Journal:  Drug Discov Today       Date:  2018-04-10       Impact factor: 7.851

Review 3.  Nanogels Capable of Triggered Release.

Authors:  Viktor Korzhikov-Vlakh; Tatiana Tennikova
Journal:  Adv Biochem Eng Biotechnol       Date:  2021       Impact factor: 2.635

4.  A Novel Gel-Forming Solution Based on PEG-DSPE/Solutol HS 15 Mixed Micelles and Gellan Gum for Ophthalmic Delivery of Curcumin.

Authors:  Na Sai; Xiaoxv Dong; Pingqing Huang; Longtai You; Chunjing Yang; Yi Liu; Wenping Wang; Huimin Wu; Yingchao Yu; Yuanyuan Du; Xin Leng; Xingbin Yin; Changhai Qu; Jian Ni
Journal:  Molecules       Date:  2019-12-24       Impact factor: 4.411

5.  Ciprofloxacin self-dissolvable Soluplus based polymeric films: a novel proposal to improve the management of eye infections.

Authors:  Antonio J Guillot; Dimitris Petalas; Pari Skondra; Hortensia Rico; Teresa M Garrigues; Ana Melero
Journal:  Drug Deliv Transl Res       Date:  2021-02-02       Impact factor: 4.617

Review 6.  Nanogels as nanocarriers for drug delivery: A review.

Authors:  Rahul Rajput; Jitendra Narkhede; Jitendra Naik
Journal:  ADMET DMPK       Date:  2019-12-21

Review 7.  Physically stimulus-responsive nanoparticles for therapy and diagnosis.

Authors:  Fatemeh Farjadian; Soheila Ghasemi; Mohsen Akbarian; Mojtaba Hoseini-Ghahfarokhi; Mohsen Moghoofei; Mohammad Doroudian
Journal:  Front Chem       Date:  2022-09-14       Impact factor: 5.545

8.  Cubic and hexagonal liquid crystal gels for ocular delivery with enhanced effect of pilocarpine nitrate on anti-glaucoma treatment.

Authors:  Wang Xingqi; Zhang Yong; Li Xing; Wang Yang; Huang Jie; Hu Rongfeng; Gui Shuangying; Chu Xiaoqin
Journal:  Drug Deliv       Date:  2019-12       Impact factor: 6.419

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.